Folks, you might remember a couple of post from days back in which I put forth similarities between KERX and RMTI in terms of closeness of FDA approval dates (Sept. 2014 and January 2015, respectively), both peaked at $18 and shorted down to low single digit level, similitarities in short interest and price fluctuations during, precisely, past 3+ years, institutional owners, etc. Well, here’s a post from the RMTI board that you might find interesting..
RMTIlong 15 days ago
$RMTI conversation
“@Anonymous Yea I do. that's the point, we are all waiting for that day. And yea, no-one will care once Triferic starts making money. But if it sells in a year with no additional trials or any effort by RMTI you have to ask yourself why was it not sold 3 years ago.
The issue is a lot of insiders at RMTI including board members have stolen millions of dollars from us while saying we're close. The reality is THEY HAD IT 3 years ago, it's called FDA approval. Everything that has happened since has kept us investors from seeing a share price of $50.
Tell me Duke... why in the h@ll are we sitting here at $5?
RC is the smartest guy in the room. DR is the next. When they do finally release Triferic for sale and the SP goes to $20 you can calculate how many tens of millions they all make be holding back long enough to acquire millions of shares at about $5.
If they had released Triferic the day after FDA approval in the bundle as RC said in many CC they would never have been able to acquire those options for less than $20 a share, likely much more.
WE HAVE ALL BEEN PLAYED.”
ALL IMO
AI
